These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 29023771)

  • 1. Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.
    Jelvehgaran P; Alderliesten T; Weda JJA; de Bruin M; Faber DJ; Hulshof MCCM; van Leeuwen TG; van Herk M; de Boer JF
    Med Phys; 2017 Dec; 44(12):6570-6582. PubMed ID: 29023771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification and comparison of visibility and image artifacts of a new liquid fiducial marker in a lung phantom for image-guided radiation therapy.
    Scherman Rydhög J; Irming Jølck R; Andresen TL; Munck Af Rosenschöld P
    Med Phys; 2015 Jun; 42(6):2818-26. PubMed ID: 26127034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers.
    Machiels M; van Hooft J; Jin P; van Berge Henegouwen MI; van Laarhoven HM; Alderliesten T; Hulshof MC
    Gastrointest Endosc; 2015 Oct; 82(4):641-9. PubMed ID: 25957478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer.
    de Blanck SR; Scherman-Rydhög J; Siemsen M; Christensen M; Baeksgaard L; Irming Jølck R; Specht L; Andresen TL; Persson GF
    Br J Radiol; 2018 Dec; 91(1092):20180236. PubMed ID: 29975152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
    Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
    Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom.
    Schneider S; Jølck RI; Troost EGC; Hoffmann AL
    Med Phys; 2018 Jan; 45(1):37-47. PubMed ID: 29136287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Liquid Fiducial Marker in Esophageal Cancer Image Guided Radiation Therapy: Technical Feasibility and Visibility on Imaging.
    Machiels M; Voncken FEM; Jin P; van Dieren JM; Bartels-Rutten A; Alderliesten T; Aleman BMP; van Hooft JE; Hulshof MCCM
    Pract Radiat Oncol; 2019 Nov; 9(6):e506-e515. PubMed ID: 31279938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion of planning CT and cystoscopy images for bladder tumor delineation: a feasibility study.
    Dees-Ribbers HM; Pos FJ; Betgen A; Bex A; Hulshof MC; Remeijer P; van Herk M
    Med Phys; 2013 May; 40(5):051713. PubMed ID: 23635261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
    Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of optimal fiducial marker across image-guided radiation therapy (IGRT) modalities: visibility and artifact analysis of gold, carbon, and polymer fiducial markers.
    Handsfield LL; Yue NJ; Zhou J; Chen T; Goyal S
    J Appl Clin Med Phys; 2012 Sep; 13(5):3976. PubMed ID: 22955665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative evaluation of fiducial markers for radiotherapy imaging.
    Chan MF; Cohen GN; Deasy JO
    Technol Cancer Res Treat; 2015 Jun; 14(3):298-304. PubMed ID: 25230715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel artifact-robust and highly visible zinc solid fiducial marker for kilovoltage x-ray image-guided radiation therapy.
    Wang T; Inubushi S; Ikeo N; Mukai T; Okumura K; Akasaka H; Yada R; Yoshida K; Miyawaki D; Ishihara T; Nakaoka A; Sasaki R
    Med Phys; 2020 Oct; 47(10):4703-4710. PubMed ID: 32696571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
    Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
    Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of carina-based versus bony anatomy-based registration for setup verification in esophageal cancer radiotherapy.
    Machiels M; Jin P; van Gurp CH; van Hooft JE; Alderliesten T; Hulshof MCCM
    Radiat Oncol; 2018 Mar; 13(1):48. PubMed ID: 29562919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy.
    Fernandez DC; Hoffe SE; Barthel JS; Vignesh S; Klapman JB; Harris C; Almhanna K; Biagioli MC; Meredith KL; Feygelman V; Rao NG; Shridhar R
    Pract Radiat Oncol; 2013; 3(1):32-39. PubMed ID: 24674261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
    Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
    Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
    Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM
    Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of fiducial markers for target positioning in proton radiotherapy of oesophageal carcinoma.
    Apolle R; Brückner S; Frosch S; Rehm M; Thiele J; Valentini C; Lohaus F; Babatz J; Aust DE; Hampe J; Troost EGC
    Radiother Oncol; 2019 Apr; 133():28-34. PubMed ID: 30935578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the Abdomen.
    Slagowski JM; Colbert LE; Cazacu IM; Singh BS; Martin R; Koay EJ; Taniguchi CM; Koong AC; Bhutani MS; Herman JM; Beddar S
    Pract Radiat Oncol; 2020; 10(6):434-442. PubMed ID: 31988039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.